The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

In this interview with Sonia Madigan, Professor Sam Wang of Princeton University discusses the development and potential of BlinkLab’s (ASX:BB1) AI-driven smartphone app, designed to screen for autism and ADHD. He discusses the science behind the MedTech technology; the progress toward obtaining FDA approval; and, the real potential to develop screening for further neurological conditions. Professor Wang also highlights the strategic collaborations with other prestigious academic institutions.

bb1 by the numbers
More From The Market Online

OzAurum Resources kicks off grade control drilling at Mulgabbie North

OzAurum Resources is ramping up development of the Mulgabbie North gold project in Western Australia with…
Koala mattress concept

Aussie mattress company Koala is launching an IPO next month. Is it another GYG?

Let’s ignore the war and look ahead to April when hopefully some of this uncertainty has psychologically normalised in the minds of traders

BlinkLab forms partnership with US autism foundation

BlinkLab’s collaboration the SHANK2 foundation will provide it with access to genetically confirmed patient populations.
Gold oil

Week 11 CY26, Wrapped: Oil meme trade steals gold thunder; Iran scarier than thought; RBA hikes locked in

This finance journalist has a confession to make to kick off this week’s wrap: he has never known what the hell an ‘ide’